Patanjali foods has announced a significant employee stock option grant, with its board committee approving 52,71,793 stock options for eligible employees under the company's ESOP 2023 plan. The Nomination and Remuneration Committee made this approval on February 11, 2026, marking the fourth major grant under the current employee stock option scheme.

ESOP Grant Details

The latest grant, designated as "ESOP Grant IV," falls within the shareholders' approved limit of 3,07,35,849 options under the PFL Employee Stock Option Plan 2023. Each option represents one equity share of the company with a face value of Rs. 2 per share.

Pricing and Exercise Terms

The exercise price structure offers attractive terms for employees, with options priced at a 20% discount to the latest available closing price. This discount applies to the highest volume trading exchange between BSE Limited and National Stock Exchange of India Limited on the last trading day before the grant date.

Once vested, employees have a three-year window to exercise their options. The vesting schedule and conditions are determined by the Nomination and Remuneration Committee at the time of each grant, providing flexibility in implementation.

Current ESOP Performance Metrics

The company's ESOP scheme shows active participation from employees, with significant exercise activity recorded:

The exercise of 7,04,430 options has generated Rs. 81,35,36,699.88 for the company, while 11,79,753 options have lapsed due to non-acceptance and employee resignations. The diluted earnings per share stands at Rs. 11.86 on a non-annualized basis.

Regulatory Compliance

The PFL Employee Stock Option Plan 2023 operates in full compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The scheme administration remains under the oversight of the Nomination and Remuneration Committee of the Board of Directors, ensuring proper governance and adherence to regulatory requirements.

This latest grant reinforces the company's commitment to employee participation in its growth story, providing eligible staff members with opportunities to benefit from the company's performance through equity participation.

Patanjali Foods Limited has announced that its Board of Directors will convene on February 11, 2026, to review and approve the company's quarterly financial performance. The meeting has been scheduled in compliance with Regulation 29 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Meeting Agenda and Financial Results

The board meeting will focus on considering and approving the unaudited standalone and consolidated financial results for two key periods:

During the meeting, the board will also take on record the Limited Review Report issued by the company's statutory auditors, ensuring proper oversight and compliance with regulatory requirements.

Trading Window Restrictions

In accordance with the Securities and Exchange Board of India Prohibition of Insider Trading Regulations, 2015, and the company's internal Code of Conduct, specific trading restrictions have been implemented. The trading window will remain closed for designated persons and their immediate relatives until 48 hours after the declaration of the unaudited financial results.

This measure is designed to regulate, monitor, and report trading activities by individuals who may have access to unpublished price-sensitive information during the financial results preparation and announcement period.

Regulatory Compliance

The announcement demonstrates Patanjali Foods Limited's commitment to maintaining transparency and adhering to regulatory requirements. The company has formally notified both BSE Limited and the National Stock Exchange of India Limited about the scheduled board meeting, ensuring all stakeholders are informed in advance.

The communication was signed by Ramji Lal Gupta, Company Secretary, and dated February 3, 2026, providing adequate notice to market participants and regulatory authorities about the upcoming financial results announcement.